Wells Fargo’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Wells Fargo’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-943	Closed	-$94K	–	6747
2015 Q1	$94K	Buy	943 +112	+13%	+$7.46K	﹤0.01%	4766
2014 Q4	$44K	Buy	831 +404	+95%	+$11.9K	﹤0.01%	5060
2014 Q3	$11K	Sell	427 -192	-31%	-$4.08K	﹤0.01%	5563
2014 Q2	$14K	Buy	+619	New	+$13.5K	﹤0.01%	5534

Wells Fargo's ASPX Position: Q2 2015 in Review

Wells Fargo sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 943 shares — an estimated $94K sold.

Wells Fargo first reported a position in ASPX in Q2 2014 and held it in 4 quarters. The position peaked at $94K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Wells Fargo reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Wells Fargo sold 943 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $94K.
Wells Fargo first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
Wells Fargo's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $94K in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Wells Fargo's 13F filing for Q2 2015, filed 14 Aug 2015.